First Drug to Slow Alzheimer's Disease Approved in Japan

Japan has approved the first drug, Leqembi, to slow the progression of Alzheimer's disease. Leqembi is designed to reduce the buildup of beta-amyloid proteins in the brain of Alzheimer's patients. The studies conducted on Leqembi have shown that the drug slows down memory and cognitive decline by approximately 27% after 18 months of treatment in patients with early stages of the disease.